Paid Clinical Trials in Georgetown, TX
As of September 2026, 27 paid clinical trials are recruiting in Georgetown, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Georgetown offers studies at sites including Amel Med LLC for conditions such as Crohn's Disease, Liver Fibrosis, Parkinson Disease, Ulcerative Colitis. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Georgetown
Filter results
Newly added in Georgetown
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.
27 clinical trials
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Enhancing Attention in Elderly Using a Brain-Computer-Interface
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Top Research Study Locations in Georgetown
Researchers run research studies in Georgetown, TX at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Amel Med LLC | Crohn's Disease, Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 3 |
| GSK Investigational Site | Irritable Bowel Syndrome, Liver Diseases, Alcoholic, Metabolic Dysfunction-Associated Steatohepatitis | 3 |
| Pinnacle Clinical Research - Georgetown | MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction-associated Steatohepatitis, Type 2 Diabetes | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Advanced Medical Trials | Metabolic Dysfunction-Associated SteatoHepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 2 |
| Pinnacle Clinical Research, LLC | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| Texas Movement Disorder Specialists | Parkinson Disease, Parkinson's Disease | 2 |
| Advanced Medical Trials, LLC | Hypothyroidism | 1 |
| Amel Med | Crohn's Disease, Ulcerative Colitis | 1 |
| Mirador Therapeutics Selected Site | Crohn's Disease, Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) | 1 |
| Sun City | Mild Cognitive Impairment (MCI) | 1 |
| TX Movement Disorder Spec PLLC | Huntington Disease | 1 |
| Teva Investigational | Multiple System Atrophy | 1 |
| Texas Movement Disorder Specialists, PLLC | Parkinson Disease | 1 |
| Vima | Dystonia | 1 |
| Xencor Investigative Site | Ulcerative Colitis (UC) | 1 |
Active & Upcoming Studies in Georgetown (2026)
Recruiting trials in Georgetown grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (4 active studies)
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar · Phase 3 · Boehringer Ingelheim
- A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH · Phase 2 · GlaxoSmithKline
Neurology & pain (2 active studies)
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease · Phase 4 · Impax Laboratories, LLC
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) · Phase 2 · AskBio Inc
Common conditions studied in Georgetown
- Crohn's Disease (3 active studies)
- Liver Fibrosis (2 active studies)
- Parkinson Disease (2 active studies)
- Ulcerative Colitis (2 active studies)
- Ulcerative Colitis (UC) (2 active studies)
- Dystonia (1 active study)
Leading research sponsors in Georgetown
- Boehringer Ingelheim
- GlaxoSmithKline
- 89bio, Inc.
- AbbVie
- Hoffmann-La Roche
Frequently asked questions
How many paid clinical trials are currently recruiting in Georgetown?
There are approximately 27 recruiting clinical trials in Georgetown, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Georgetown pay participants?
Most recruiting trials in Georgetown compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Georgetown?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Georgetown?
The most common conditions under active study in Georgetown include Crohn's Disease (3), Liver Fibrosis (2), Parkinson Disease (2), Ulcerative Colitis (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Georgetown?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Georgetown on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Georgetown?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Georgetown?
Recruiting research sites in Georgetown include Amel Med LLC, GSK Investigational Site, Pinnacle Clinical Research - Georgetown, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Georgetown right now?
The largest active categories in Georgetown are Diabetes & metabolic (4), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.